Conserved enzymatic production and biological effect of O-acetyl-ADP-ribose by silent information regulator 2-like NAD+-dependent deacetylases.
Level 5 - mechanism / opinion, no new human data
Bench and cellular laboratory study (non-clinical mechanistic research)
PubMed 11812793 · doi:10.1074/jbc.M111830200
What was done
The authors examined the enzymatic generation of the metabolite O-acetyl-ADP-ribose by Sir2-like NAD+-dependent deacetylases across yeast, Drosophila, and human enzymes, as well as endogenous yeast Sir2 complexes from telomeres. Using quantitative microinjection assays, they tested the cellular effects of O-acetyl-ADP-ribose, active Sir2 enzymes (at low nanomolar concentrations), and catalytically inactive mutants on oocyte maturation and blastomere cell division. They also assayed cell-free oocyte extracts for enzymatic metabolism of O-acetyl-ADP-ribose.
What was found
O-acetyl-ADP-ribose synthesis was confirmed to be conserved across yeast, Drosophila, and human Sir2 homologs and present in endogenous yeast Sir2 telomeric complexes. Microinjection of O-acetyl-ADP-ribose caused a delay or block in both oocyte maturation and blastomere embryonic cell division. This arrest was replicated by microinjecting low nanomolar concentrations of active Sir2 enzyme, but not by a catalytically impaired mutant. Cell-free oocyte extracts demonstrated endogenous enzymatic activity capable of utilizing O-acetyl-ADP-ribose. The abstract reported no specific numerical metrics or statistical values.
Why it matters
This study establishes that O-acetyl-ADP-ribose is an evolutionarily conserved, biologically active metabolite of Sir2-mediated deacetylation capable of modulating key cell-cycle and developmental events.
Limits
The abstract provides no exact sample sizes, variance measures, or quantitative effect sizes. The experiments were conducted exclusively in basic in vitro and non-mammalian cellular models (oocytes, embryos, cell extracts), precluding direct conclusions about human tissue physiology.
Cited by
- supports SIRT1 requires NAD as a co-substrate, transferring the chemical group removed from epigenetic structures to NAD during its enzymatic reaction.